MDRX Insider Trading
Veradigm Inc. | Services-Computer Integrated Systems Design
Comprehensive Trading Performance Summary
The investment history of corporate insiders at Veradigm Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Services-Computer Integrated Systems Design sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2009-05-07 04:51 | 2009-05-04 | Vandenberg Brian | Officer - Senior VP and General Counsel | OPT+S | $11.97 | 19,713 | $235,896 | 65,343 | 0.0% |
| 2009-05-07 03:57 | 2009-05-04 | SHAPIRO LEE | Officer - President, COO and Secretary | OPT+S | $11.91 | 200,000 | $2,382,120 | 370,680 | 0.0% |
| 2009-05-07 03:14 | 2009-05-04 | TULLMAN GLEN | Director, Officer - Chief Executive Officer | OPT+S | $11.94 | 400,000 | $4,775,280 | 1,097,532 | 0.0% |
| 2009-05-07 03:13 | 2009-05-04 | DAVIS WILLIAM J | Officer - Chief Financial Officer | OPT+S | $11.91 | 145,000 | $1,726,457 | 340,500 | 0.0% |
| 2009-05-07 03:11 | 2009-05-04 | MCGRAW LAURIE | Officer - President, Enterprise Solution | OPT+S | $11.91 | 103,918 | $1,237,310 | 319,224 | 0.0% |
| 2009-01-17 00:02 | 2009-01-15 | CULL JOHN G | Officer - President, Medication Services | OPT+S | $8.50 | 12,154 | $103,309 | 24,189 | 0.0% |
| 2008-11-14 02:43 | 2008-11-12 | Cadbury Sir Dominic | Director | BUY | $7.27 | 10,000 | $72,700 | 10,000 | +100.0% |
| 2008-11-12 19:09 | 2008-11-10 | King John G | Director | BUY | $7.23 | 10,000 | $72,300 | 10,000 | +100.0% |
| 2008-11-04 00:57 | 2008-10-28 | Davenport Roger L. | Officer - Pres, Professional Solutions | BUY | $5.51 | 10,000 | $55,100 | 10,000 | +100.0% |
| 2008-11-04 00:55 | 2008-10-31 | KLUGER MICHAEL | Director | BUY | $6.48 | 50,000 | $324,000 | 80,745 | +162.6% |
| 2008-10-30 00:36 | 2008-10-27 | Lawrie Michael | Director, Officer - Executive Chairman | BUY | $5.09 | 70,000 | $356,300 | 70,000 | +100.0% |
| 2008-10-28 00:18 | 2008-10-27 | TULLMAN GLEN | Director, Officer - Chief Executive Officer | BUY | $5.11 | 100,000 | $511,000 | 677,951 | +17.3% |
| 2008-10-15 00:55 | 2008-09-19 | BULKLEY BENJAMIN | Officer - Chief Operating Officer | SELL | $13.00 | 8,253 | $107,289 | 8,575 | -49.0% |
| 2008-09-17 01:53 | 2008-09-15 | TULLMAN GLEN | Director, Officer - Chief Executive Officer | BUY | $12.99 | 7,413 | $96,295 | 577,951 | +1.3% |
| 2008-08-29 04:00 | 2008-08-26 | CULL JOHN G | Officer - President, Medication Services | SELL | $14.52 | 195 | $2,831 | 9,004 | -2.1% |
| 2008-06-06 00:14 | 2008-06-03 | CULL JOHN G | Officer - President, Medication Services | OPT+S | $12.50 | 3,000 | $37,500 | 9,199 | 0.0% |
| 2008-04-04 01:25 | 2007-08-24 | CULL JOHN G | Officer - President, Medication Services | SELL | $22.52 | 194 | $4,369 | 6,446 | -2.9% |
| 2008-02-28 01:07 | 2008-02-26 | CULL JOHN G | Officer - President, Medication Services | OPT+S | $12.00 | 5,163 | $61,956 | 9,208 | 0.0% |
| 2008-02-27 01:59 | 2008-02-26 | Trumato Donato | Officer - Pres., Physicians Interactive | SELL | $11.84 | 814 | $9,638 | 18,313 | -4.3% |
| 2007-10-03 23:31 | 2007-10-02 | LEISHER THOMAS S | Officer - President, eRx | OPT+S | $27.30 | 15,250 | $416,284 | 54,086 | 0.0% |
| 2007-10-03 00:33 | 2007-10-01 | Bond David A | Officer - President, SMB Solutions | SELL | $27.61 | 5,000 | $138,072 | 78,798 | -6.0% |
| 2007-08-15 21:45 | 2007-08-09 | Bond David A | Officer - President, SMB Solutions | SELL | $26.00 | 5,000 | $130,000 | 84,015 | -5.6% |
| 2007-07-06 01:23 | 2007-07-02 | LEISHER THOMAS S | Officer - President, eRx | OPT+S | $25.01 | 15,250 | $381,351 | 48,070 | 0.0% |
| 2007-04-05 02:54 | 2007-04-02 | TULLMAN GLEN | Director, Officer - Chief Executive Officer | OPT+S | $26.36 | 167,000 | $4,401,986 | 314,497 | 0.0% |
| 2007-04-05 02:52 | 2007-04-02 | DAVIS WILLIAM J | Officer - Chief Financial Officer | OPT+S | $26.36 | 36,000 | $948,931 | 17,513 | 0.0% |
| 2007-04-05 02:51 | 2007-04-02 | SHAPIRO LEE | Officer - President | OPT+S | $26.36 | 64,437 | $1,698,508 | 36,384 | 0.0% |
| 2007-04-05 02:49 | 2007-04-02 | CAREY JOSEPH E | Officer - Chief Operating Officer | OPT+S | $26.36 | 71,771 | $1,891,826 | 17,513 | 0.0% |
| 2007-04-05 02:47 | 2007-04-02 | MCGRAW LAURIE | Officer - President, Clinical Solutions | OPT+S | $26.36 | 30,121 | $793,965 | 16,409 | 0.0% |
| 2007-04-05 02:45 | 2007-04-02 | Bond David A | Officer - President, SMB Solutions | SELL | $26.34 | 5,000 | $131,700 | 68,236 | -6.8% |
| 2007-03-08 05:56 | 2007-03-05 | MCCONNELL JOHN P | Director | SELL | $25.19 | 516,672 | $13,015,639 | 420,080 | -55.2% |
| 2007-03-06 23:47 | 2007-03-05 | CULL JOHN G | Officer - President, Medication Services | OPT+S | $25.54 | 10,000 | $255,400 | 6,640 | 0.0% |
| 2007-02-21 00:30 | 2007-02-15 | CAREY JOSEPH E | Officer - Chief Operating Officer | OPT+S | $28.30 | 71,770 | $2,031,091 | 17,513 | 0.0% |
| 2007-02-21 00:29 | 2007-02-15 | SHAPIRO LEE | Officer - President | OPT+S | $28.30 | 64,437 | $1,823,567 | 36,384 | 0.0% |
| 2007-02-21 00:28 | 2007-02-15 | DAVIS WILLIAM J | Officer - Chief Financial Officer | OPT+S | $28.30 | 36,000 | $1,018,800 | 17,513 | 0.0% |
| 2007-02-21 00:26 | 2007-02-15 | Bond David A | Officer - President, SMB Solutions | SELL | $28.30 | 5,000 | $141,500 | 46,867 | -9.6% |
| 2007-02-21 00:25 | 2007-02-15 | TULLMAN GLEN | Officer - Chief Executive Officer | OPT+S | $28.30 | 167,000 | $4,726,100 | 314,497 | 0.0% |
| 2007-02-21 00:23 | 2007-02-15 | MCGRAW LAURIE | Officer - President, Clinical Solutions | OPT+S | $28.30 | 30,121 | $852,424 | 16,409 | 0.0% |
| 2006-12-02 02:24 | 2006-12-01 | HUSAIN FAZLE M | Director | OPT+S | $27.02 | 45,000 | $1,215,900 | 40,697 | 0.0% |
| 2006-11-22 21:42 | 2006-11-21 | COMPTON ROBERT A | Director | SELL | $27.04 | 10,169 | $274,970 | 53,420 | -16.0% |
| 2006-11-17 01:05 | 2006-11-16 | HUSAIN FAZLE M | Director | SELL | $26.22 | 5,000 | $131,100 | 41,627 | -10.7% |
| 2006-11-16 01:47 | 2006-11-14 | GOLDSTEIN BERNARD | Director | OPT+S | $25.95 | 5,000 | $129,750 | 58,028 | 0.0% |
| 2006-11-15 01:46 | 2006-11-09 | GOLDSTEIN BERNARD | Director | OPT+S | $25.46 | 15,000 | $381,851 | 58,028 | 0.0% |
| 2006-11-14 17:37 | 2006-11-10 | KLUGER MICHAEL | Director | SELL | $25.31 | 75,000 | $1,898,250 | 30,745 | -70.9% |
| 2006-11-13 17:50 | 2006-11-08 | GOLDSTEIN BERNARD | Director | OPT+S | $24.38 | 5,000 | $121,900 | 58,028 | 0.0% |
| 2006-11-13 17:49 | 2006-11-09 | Bond David A | Officer - President, SMB Solutions | SELL | $25.00 | 6,000 | $150,000 | 51,867 | -10.4% |
| 2006-09-13 23:18 | 2006-09-12 | Bond David A | Officer - President, SMB Solutions | SELL | $21.00 | 6,000 | $126,000 | 57,867 | -9.4% |
| 2006-09-07 23:53 | 2006-09-05 | CULL JOHN G | Officer - President, Medication Services | OPT+S | $21.00 | 9,166 | $192,486 | 7,045 | 0.0% |
| 2006-08-15 21:31 | 2006-08-11 | COMPTON ROBERT A | Director | OPT+S | $21.32 | 15,000 | $319,800 | 88,589 | 0.0% |
| 2006-08-09 00:12 | 2006-08-04 | Green Philip D | Director | OPT+S | $21.00 | 54,800 | $1,150,800 | 28,940 | 0.0% |
| 2006-08-09 00:06 | 2006-08-04 | DAVIS WILLIAM J | Officer - Chief Financial Officer | OPT+S | $21.00 | 90,000 | $1,890,000 | 18,182 | 0.0% |
How to Interpret $MDRX Trades
Not every insider transaction in Veradigm Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $MDRX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for MDRX
Insider activity data for Veradigm Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $MDRX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.